When Your Mood Isn’t “Just Stress”: Hormonal Mood Disorders Across a Woman’s Life

In my practice, I meet a particular kind of client again and again: high-achieving, insightful, often already in therapy for anxiety or burnout, who says some version of “something’s off, but I can’t point to why.” She’s not imagining it. And more often than she’s been told, the answer isn’t purely psychological—it’s endocrine. 

Hormonal mood disorders are chronically underdiagnosed, in part because our field has historically treated hormones and mood as separate systems to be handled by separate providers: a therapist for the mind, a gynecologist for the body—when for many women they are the same system.

High-achieving women in particular tend to be excellent at managing symptoms through sheer competence: pushing through, compensating, attributing a bad week to workload. That skill is also what delays diagnosis.

I want to walk through three points in the reproductive life cycle where hormonal shifts can produce real, diagnosable mood disorders, and why recognizing the pattern matters clinically.

Women’s Reproductive Cycle and Hormonal Shifts

Premenstrual Dysphoric Disorder: More Than “Bad PMS”

PMDD is frequently minimized as an intense version of premenstrual syndrome, but it’s a distinct DSM-5 diagnosis with a distinct mechanism.

A large 2024 systematic review and meta-analysis led by researchers at Oxford’s Department of Psychiatry found that roughly 1.6% of women and girls meet strict diagnostic criteria for confirmed PMDD, with another 3.2% meeting criteria for a provisional diagnosis—together representing tens of millions of women worldwide whose symptoms are frequently missed because they haven’t been tracked systematically enough to confirm the diagnosis.

That gap is the clinical story: PMDD isn’t rare so much as it’s under-caught, because it requires prospective daily symptom tracking across at least two cycles to diagnose properly, and most women (and many clinicians) are working from memory and impression instead. 

What makes PMDD clinically distinct from typical PMS is severity and functional impairment—the mood, irritability, and cognitive symptoms (difficulty concentrating, memory complaints) are disruptive enough to interfere with work and relationships, not just uncomfortable.

I also see PMDD intersect meaningfully with ADHD in my caseload, which tracks with recent research: a 2025 British Journal of Psychiatry study found the prevalence of provisional PMDD was substantially elevated among women with clinically diagnosed ADHD compared with non-ADHD peers, suggesting shared vulnerability in how the brain responds to hormonal shifts.

For the perfectionistic, high-functioning women I treat, PMDD often gets reframed internally as a character flaw—”I’m just bad at handling stress a few days a month”—rather than named as a hormone-mediated mood disorder with legitimate treatment pathways, including SSRIs dosed luteal-phase-only, hormonal suppression of ovulation, and CBT adapted for cyclical symptoms.

Postpartum Depression and the Perfectionism Connection 

Postpartum depression affects roughly 6.5–12.9% of women in high-income countries, and this is one area where the research directly implicates the personality profile I specialize in.

A case-control study comparing women with major postpartum depression to healthy postpartum controls found that high perfectionism was significantly more common in the depressed group (34% versus 11%), and that one specific dimension—concern over mistakes—more than quadrupled the odds of major postpartum depression independent of other risk factors. Neuroticism and personal psychiatric history were also independent predictors, but concern-over-mistakes perfectionism stood out as a distinct, measurable vulnerability. 

Clinically, this matters because it reframes what we’re looking for. A new mother who is organized, prepared, and outwardly “handling it” is not automatically at lower risk—her perfectionism may be exactly what predisposes her to a major depressive episode when the inevitable gap opens between her internal standard for mothering and the chaotic, imperfect reality of early postpartum life.

The hormonal piece—the abrupt withdrawal of estrogen and progesterone after delivery, compounded by sleep deprivation—creates the biological vulnerability; the concern-over-mistakes cognitive style determines who’s most likely to develop full major depression rather than transient adjustment difficulty.

Screening for perfectionism, not just mood symptoms, may catch women who would otherwise present as too competent to be at risk. 

Perimenopause: The Most Underrecognized Window 

Of the three, perimenopause is the stage I see missed most often in adult women’s own self-understanding, partly because it doesn’t announce itself the way a menstrual cycle or a pregnancy does.

A 2024 meta-analysis published in the Journal of Affective Disorders found that perimenopausal women have approximately 40% higher risk of depressive symptoms and diagnosed depression compared with premenopausal women—and, notably, that elevated risk resolves once women reach postmenopause. It isn’t menopause itself that destabilizes mood; it’s the transition, and specifically hormonal instability rather than hormonal decline. 

The mechanism research bears this out. Rather than low estrogen driving depression, several studies point to estradiol fluctuation—the erratic rise and fall, rather than a steady decline—as the more relevant variable, with week-to-week estradiol variability associated with increased depressive symptoms, anger, and sensitivity to social rejection.

One line of research frames this as an increased sensitivity to psychosocial stress: when significant estradiol fluctuation coincides with a stressful life event—a divorce, a bereavement, a career disruption—the combination appears to meaningfully raise risk for a clinically significant depressive episode.

For my caseload of women in their 40s and early 50s, this has real diagnostic value: a woman who has never had a mood disorder and is suddenly struggling in the context of both hormonal transition and major life stress isn’t experiencing a personal failure to cope—she’s experiencing a well-documented biological vulnerability window, and one where treatments including transdermal estradiol and SSRIs both have evidence behind them. 

Why This Matters for How We Treat Women 

Across all three of these windows—the luteal phase, the postpartum period, and the menopause transition—the pattern is the same: real hormonal mechanisms producing real mood disorders, frequently misread by the women experiencing them (and sometimes by their clinicians) as personal or characterological.

For the high-achieving women I work with, that misreading tends to compound the problem, because it gets absorbed into an existing narrative of not being resilient enough, not managing well enough, not being disciplined enough.

Part of my work is separating the biological signal from the self-critical story built around it—not to dismiss the psychological work, which still matters enormously, but to make sure it isn’t being asked to do a job that belongs to endocrinology, timing, and appropriately targeted treatment. 

If you’re navigating one of these transitions and finding that your usual coping strategies aren’t landing the way they used to, that’s worth taking seriously—not as evidence you’re falling short, but as information about what’s actually happening in your body.